Long-Term Clinical Outcome After a First Angiographically Confirmed Coronary Stent Thrombosis An Analysis of 431 Cases

被引:131
作者
van Werkum, Jochem W. [1 ,4 ]
Heestermans, Antonius A. C. M. [2 ]
de Korte, Fleur I. [1 ]
Kelder, Johannes C. [1 ]
Suttorp, Maarten-Jan [1 ]
Rensing, Benno J. W. M. [1 ]
Zwart, Bastiaan [1 ]
Brueren, B. R. Guus [3 ]
Koolen, Jacques J. [3 ]
Dambrink, Jan-Henk E. [2 ]
van't Hof, Arnoud W. J. [2 ]
Verheugt, Freek W. A. [4 ]
ten Berg, Jurrien M. [1 ]
机构
[1] St Antonius Hosp, Dept Cardiol, NL-3435 CM Nieuwegein, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Cardiol, Nijmegen, Netherlands
关键词
stents; thrombosis; risk factors; DRUG-ELUTING STENTS; IMPLANTATION; PREDICTORS; TRIALS;
D O I
10.1161/CIRCULATIONAHA.108.799403
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-There are limited data on the long-term clinical outcome after an angiographically confirmed (definite) stent thrombosis (ST). Methods and Results-Four hundred thirty-one consecutive patients with a definite ST were enrolled in this multicenter registry. The primary end point was the composite of cardiac death and definite recurrent ST. Secondary end points were all-cause death, cardiac death, definite recurrent ST, definite and probable recurrent ST, any myocardial infarction, and any target-vessel revascularization. The primary end point occurred in 111 patients after a median follow-up of 27.1 months. The estimated cumulative event rates at 30 days and 1, 2, and 3 years were 18.0%, 23.6%, 25.2%, and 27.9%, respectively. The cumulative incidence rates of definite recurrent ST, definite or probable recurrent ST, any myocardial infarction, and any target-vessel revascularization were 18.8%, 20.1%, 21.3%, and 32.0%, respectively, at the longest available follow-up. Independent predictors for the primary end point were diabetes mellitus, total stent length, severe calcification, American College of Cardiology/American Heart Association B2-C lesions, TIMI (Thrombolysis In Myocardial Infarction) flow grade <3 after percutaneous coronary intervention, and left ventricular ejection fraction <45%. The implantation of an additional coronary stent during the first ST was also associated with unfavorable outcome. Clinical outcome was not affected by the type of previously implanted stent (drug-eluting or bare-metal stent) or the category of ST (early versus late). Conclusions-The long-term clinical outcome after a first definite ST is unfavorable, with a high mortality and recurrence rate. Diabetes mellitus, left ventricular ejection fraction <45%, long total stent length, complex coronary lesions, TIMI flow grade <3 after percutaneous coronary intervention, and implantation of an additional coronary stent during the emergent percutaneous coronary intervention for the ST were associated with this unfavorable outcome. (Circulation. 2009;119:828-834.)
引用
收藏
页码:828 / 834
页数:7
相关论文
共 12 条
[1]   Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment [J].
Airoldi, Flavio ;
Colombo, Antonio ;
Morici, Nuccia ;
Latib, Azeem ;
Cosgrave, John ;
Buellesfeld, Lutz ;
Bonizzoni, Erminio ;
Carlino, Mauro ;
Gerckens, Ulrich ;
Godino, Cosmo ;
Melzi, Gloria ;
Michev, Iassen ;
Montorfano, Matteo ;
Sangiorgi, Giuseppe Massimo ;
Qasim, Asif ;
Chieffo, Alaide ;
Briguori, Carlo ;
Grube, Eberhard .
CIRCULATION, 2007, 116 (07) :745-754
[2]   The volume of primary angioplasty procedures and survival after acute myocardial infarction [J].
Canto, JG ;
Every, NR ;
Magid, DJ ;
Rogers, WJ ;
Malmgren, JA ;
Frederick, PD ;
French, WJ ;
Tiefenbrunn, AJ ;
Misra, VK ;
Kiefe, CI ;
Barron, HV .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) :1573-1580
[3]  
Cutlip DE, 2001, CIRCULATION, V103, P1967
[4]   Clinical end points in coronary stent trials - A case for standardized definitions [J].
Cutlip, Donald E. ;
Windecker, Stephan ;
Mehran, Roxana ;
Boam, Ashley ;
Cohen, David J. ;
van Es, Gerrit-Anne ;
Steg, P. Gabriel ;
Morel, Marie-angele ;
Mauri, Laura ;
Vranckx, Pascal ;
McFadden, Eugene ;
Lansky, Alexandra ;
Hamon, Martial ;
Krucoff, Mitchell W. ;
Serruys, Patrick W. .
CIRCULATION, 2007, 115 (17) :2344-2351
[5]   Drug-eluting stent thrombosis -: Results from the Multicenter Spanish registry ESTROFA (Estudio ESpanol sobre TROmbosis de stents FArmacoactivos) [J].
de la Torre-Hernandez, Jos M. ;
Alfonso, Fernando ;
Hernandez, Felipe ;
Elizaga, Jaime ;
Sanmartin, Marcelo ;
Pinar, Eduardo ;
Lozano, Inigo ;
Vazquez, Jose M. ;
Botas, Javier ;
Perez de Prado, Armando ;
Hernandez, Jose M. ;
Sanchis, Juan ;
Ruiz Nodar, Juan M. ;
Gomez-Jaume, Alfredo ;
Larman, Mariano ;
Diarte, Jose A. ;
Rodriguez-Collado, Javier ;
Rumoroso, Jose R. ;
Lopez-Minguez, Jose R. ;
Mauri, Josepa .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) :986-990
[6]   Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents [J].
Iakovou, I ;
Schmidt, T ;
Bonizzoni, E ;
Ge, L ;
Sangiorgi, GM ;
Stankovic, G ;
Airoldi, F ;
Chieffo, A ;
Montorfano, M ;
Carlino, M ;
Michev, I ;
Corvaja, N ;
Briguori, C ;
Gerckens, U ;
Grube, E ;
Colombo, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (17) :2126-2130
[7]   Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents [J].
Kuchulakanti, PK ;
Chu, WW ;
Torguson, R ;
Ohlmann, P ;
Rha, SW ;
Clavijo, LC ;
Kim, SW ;
Bui, A ;
Gevorkian, N ;
Xue, ZY ;
Smith, K ;
Fournadjieva, J ;
Suddath, WO ;
Satler, LF ;
Pichard, AD ;
Kent, KM ;
Waksman, R .
CIRCULATION, 2006, 113 (08) :1108-1113
[8]   Stent thrombosis in randomized clinical trials of drug-eluting stents [J].
Mauri, Laura ;
Hsieh, Wen-hua ;
Massaro, Joseph M. ;
Ho, Kalon K. L. ;
D'Agostino, Ralph ;
Cutlip, Donald E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (10) :1020-1029
[9]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[10]   Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up [J].
Park, Duk-Woo ;
Park, Seong-Wook ;
Park, Kyoung-Ha ;
Lee, Bong-Ki ;
Kim, Young-Hak ;
Lee, Cheol Whan ;
Hong, Myeong-Ki ;
Kim, Jae-Joong ;
Park, Seung-Jung .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03) :352-356